Linking the complement system to endometriosis pathogenesis: a systematic review of diagnostic potential

Andrea Balduit, Paola Trevisiol, Gabriella Zito, Giovanni Di Lorenzo, Giuseppe Ricci, Roberta Bulla, Chiara Agostinis
In: Frontiers in Immunology · 2026 · vol. 17 · doi:10.3389/fimmu.2026.1991241 · W7226003112
OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher

Abstract

Endometriosis (EM) is a chronic gynecological disorder affecting roughly 5-10% of women in their reproductive age, with symptom onset often occurring during adolescence but diagnosis frequently delayed for several years. Its pathogenesis is multifactorial, involving immunological, hormonal, genetic, and environmental factors. Increasing evidence suggests that immune dysregulation, particularly involving the complement system, a key effector of innate immunity and mediator of inflammatory responses, contributes to EM pathogenesis by sustaining chronic inflammation, angiogenesis, and lesion development. This review summarizes the available evidence on the involvement of complement components in EM pathogenesis and evaluates their potential use as biomarkers. A systematic literature search was performed in PubMed, Scopus, and Embase following PRISMA guidelines, including all eligible studies published up to July 2026. After full-text screening, 64 of 652 studies were selected and included in the final analysis. Overall, evidence supported a predominant involvement of the alternative complement pathway in EM, with complement component C3 emerging as the most extensively investigated molecule (35/64 studies). Evidence for the classical and lectin pathways was comparatively limited and heterogeneous. Moreover, several complement regulators emerged as differentially expressed in transcriptomic studies of endometriotic lesions. Overall, complement dysregulation appeared to be predominantly localized to the lesion microenvironment, while evidence of systemic complement activation remained limited. C3, C7, and FH emerged as the most consistently dysregulated molecules and appeared to be promising candidates for a complement-based biomarker panel for EM. Further validation in well-characterized and independent cohorts is required to determine their diagnostic value.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

openalex
last seen: 2026-11-15T06:03:07.880986+00:00
License: CC0 · commercial use OK